These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

834 related items for PubMed ID: 21269482

  • 1. Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats.
    Ji G, Zhao X, Leng L, Liu P, Jiang Z.
    Lipids Health Dis; 2011 Jan 26; 10():23. PubMed ID: 21269482
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment.
    Vilà L, Rebollo A, Ađalsteisson GS, Alegret M, Merlos M, Roglans N, Laguna JC.
    Toxicol Appl Pharmacol; 2011 Feb 15; 251(1):32-40. PubMed ID: 21122807
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.
    Li S, Liao X, Meng F, Wang Y, Sun Z, Guo F, Li X, Meng M, Li Y, Sun C.
    PLoS One; 2014 Feb 15; 9(1):e86724. PubMed ID: 24489777
    [Abstract] [Full Text] [Related]

  • 7. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism.
    Yin Y, Yu Z, Xia M, Luo X, Lu X, Ling W.
    Eur J Clin Invest; 2012 Nov 15; 42(11):1189-96. PubMed ID: 22958216
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens.
    Martín-Castillo A, Castells MT, Adánez G, Polo MT, Pérez BG, Ayala I.
    Biomed Pharmacother; 2010 Apr 15; 64(4):275-81. PubMed ID: 19932590
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis.
    Gao Y, Song LX, Jiang MN, Ge GY, Jia YJ.
    Inflammation; 2008 Apr 15; 31(2):121-32. PubMed ID: 18302012
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selenium and vitamin B6 cosupplementation improves dyslipidemia and fatty liver syndrome by SIRT1/SREBP-1c pathway in hyperlipidemic Sprague-Dawley rats induced by high-fat diet.
    Zhang Q, Zhou X, Zhang J, Li Q, Qian Z.
    Nutr Res; 2022 Oct 15; 106():101-118. PubMed ID: 36183668
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway.
    Bian Y, Li X, Li X, Ju J, Liang H, Hu X, Dong L, Wang N, Li J, Zhang Y, Yang B.
    Biomed Pharmacother; 2019 Sep 15; 117():109176. PubMed ID: 31387185
    [Abstract] [Full Text] [Related]

  • 18. Atorvastatin increases hepatic fatty acid beta-oxidation in sucrose-fed rats: comparison with an MTP inhibitor.
    Funatsu T, Kakuta H, Takasu T, Miyata K.
    Eur J Pharmacol; 2002 Nov 29; 455(2-3):161-7. PubMed ID: 12445582
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the guinea pig: atorvastatin versus simvastatin.
    Conde K, Pineda G, Newton RS, Fernandez ML.
    Biochem Pharmacol; 1999 Oct 01; 58(7):1209-19. PubMed ID: 10484079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.